|
PSMC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.205620E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.553800E-01 |
| Normal-vs-Stage2 |
3.806800E-01 |
| Normal-vs-Stage3 |
6.597800E-02 |
| Normal-vs-Stage4 |
8.763500E-03 |
| Stage1-vs-Stage2 |
7.225800E-01 |
| Stage1-vs-Stage3 |
1.952000E-01 |
| Stage1-vs-Stage4 |
2.422400E-02 |
| Stage2-vs-Stage3 |
6.035800E-01 |
| Stage2-vs-Stage4 |
2.579800E-01 |
| Stage3-vs-Stage4 |
3.895200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.204380E-01 |
| Normal-vs-AfricanAmerican |
9.051800E-01 |
| Normal-vs-Asian |
5.488800E-01 |
| Caucasian-vs-AfricanAmerican |
3.030400E-01 |
| Caucasian-vs-Asian |
5.948400E-01 |
| AfricanAmerican-vs-Asian |
5.793800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.292000E-02 |
| Normal-vs-Female |
1.890360E-01 |
| Male-vs-Female |
4.122600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.163000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.843800E-02 |
| Normal-vs-Age(61-80Yrs) |
3.338200E-02 |
| Normal-vs-Age(81-100Yrs) |
4.381000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.692300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.831600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.128800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.188600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.987200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.183800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.308600E-01 |
| Classical-VS-Follicular |
1.185830E-02 |
| Classical-VS-Other |
9.093200E-01 |
| Classical-VS-Normal |
6.591200E-01 |
| Tall-VS-Follicular |
3.095200E-01 |
| Tall-VS-Other |
7.422000E-01 |
| Tall-VS-Normal |
2.465600E-01 |
| Follicular-VS-Other |
4.817800E-01 |
| Follicular-VS-Normal |
1.461610E-02 |
| Other-VS-Normal |
7.658600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.500300E-02 |
| Normal-vs-N1 |
9.507900E-02 |
| N0-vs-N1 |
8.596000E-01 |
|
|
